A Study Of PF-06664178 In Patients With Advanced Solid Tumors

NCT02122146 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
31
Enrollment
INDUSTRY
Sponsor class

Stopped The study was prematurely discontinued due to a business-related decision on 09-FEB-2016. The decision to terminate the trial was based on the overall results.

Conditions

Interventions

Sponsor

Pfizer